Search details
1.
Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy.
J Biomed Inform
; 142: 104367, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37105509
2.
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
Br J Cancer
; 126(5): 693-705, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34663949
3.
Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the 'U' out of 'CUP'.
Br J Cancer
; 120(2): 141-153, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30580378
4.
Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Lancet Oncol
; 19(9): e470-e481, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30191851
5.
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.
JAMA
; 317(18): 1844-1853, 2017 05 09.
Article
in English
| MEDLINE | ID: mdl-28492898
6.
Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma.
Clin Cancer Res
; 28(10): 1999-2019, 2022 05 13.
Article
in English
| MEDLINE | ID: mdl-35091446
7.
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
Mol Oncol
; 16(10): 1969-1985, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34866317
8.
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.
Clin Cancer Res
; 27(4): 1119-1130, 2021 02 15.
Article
in English
| MEDLINE | ID: mdl-33257424
9.
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance.
Cancer Cell
; 37(4): 485-495, 2020 04 13.
Article
in English
| MEDLINE | ID: mdl-32289272
10.
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).
J Clin Oncol
; 36(12): 1232-1239, 2018 04 20.
Article
in English
| MEDLINE | ID: mdl-29528792
11.
Correlation between MEK signature and Ras gene alteration in advanced gastric cancer.
Oncotarget
; 8(64): 107492-107499, 2017 Dec 08.
Article
in English
| MEDLINE | ID: mdl-29296181
12.
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers.
Clin Cancer Res
; 23(18): 5366-5373, 2017 Sep 15.
Article
in English
| MEDLINE | ID: mdl-28615371
13.
Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
PLoS One
; 11(2): e0149628, 2016.
Article
in English
| MEDLINE | ID: mdl-26905262
14.
Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547.
Mol Cancer Ther
; 15(11): 2802-2813, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27550940
15.
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.
Cancer Discov
; 6(8): 838-851, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27179038
16.
Complexity of FGFR signalling in metastatic urothelial cancer.
J Hematol Oncol
; 8: 119, 2015 Oct 24.
Article
in English
| MEDLINE | ID: mdl-26497743
17.
Identification of centaurin-alpha2: a phosphatidylinositide-binding protein present in fat, heart and skeletal muscle.
Eur J Cell Biol
; 81(4): 222-30, 2002 Apr.
Article
in English
| MEDLINE | ID: mdl-12018390
18.
Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
PLoS One
; 8(6): e66963, 2013.
Article
in English
| MEDLINE | ID: mdl-23826179
19.
FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547.
Clin Cancer Res
; 19(9): 2572-83, 2013 May 01.
Article
in English
| MEDLINE | ID: mdl-23493349
20.
Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
Clin Cancer Res
; 18(7): 1855-62, 2012 Apr 01.
Article
in English
| MEDLINE | ID: mdl-22388515